NCT02662842 - BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Type 1 Diabetes Mellitus

Interventions

DEVICE

FlowSmart Infusion Set

Use of set for subcutaneous insulin infusion, with set change every three days.

DEVICE

Current Infusion Set

Use of set for subcutaneous insulin infusion, with set change every three days.

Trial Locations (4)

Atlanta Diabetes Associates, Atlanta

Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls

AMCR Institute Inc., Escondido

TKL Research, Fair Lawn